Rare pancreatic cancer shows strong response to immunotherapy

Cancer Research Institute announces 2025 recipients of cancer immunotherapy awards

Alan KormanAviv RegevJeffrey C. RathmellThe Cancer Research Institute announced the 2025 recipients of the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology and the Frederick W. Alt Award for New Discoveries in Immunology.

August 01, 2025

Vol.51 No.30

Clinical Roundup

Blocking macropinocytosis changes TME, allows for more effective treatment, preclinical study shows

Blocking macropinocytosis reshapes the tumor microenvironment to be less fibrous and to allow more access to immune cells, according to a preclinical study of pancreatic tumors conducted by scientists at Sanford Burnham Prebys, an NCI-designated Cancer Center.

August 01, 2025

Vol.51 No.30

In Brief

Six researchers awarded $5.3M for pancreatic cancer research by Stephenson Global

The Stephenson Global Pancreatic Cancer Research Institute and its partner, City of Hope, announced the six inaugural recipients of the Stephenson Scholar Grants, awarding $5.25 million to support high-impact research aimed at transforming the understanding, early detection, and treatment of pancreatic cancer (The Cancer Letter, Sept. 17, 2024).

July 25, 2025

Vol.51 No.29

In Brief

Dispatch Bio aims to deliver universal treatment across solid tumors with novel immunotherapy approach

Dispatch Bio, a company aiming to engineer a universal immunotherapy treatment across solid tumors, announced its official launch.

July 25, 2025

Vol.51 No.29

In Brief

SITC Forward Fund announces 2025 fellowship recipients

The Society for Immunotherapy of Cancer Forward Fund announced the recipients of the 2025 SITC Fellowships.

July 25, 2025

Vol.51 No.29

Clinical Roundup

Study reveals immune-based therapy that may be effective in hard-to-treat lung cancers

A study published today by researchers at the Translational Genomics Research Institute, part of City of Hope, and clinician-scientists at Baylor Scott & White Research Institute revealed a potential new therapeutic strategy for fighting lung cancer that harnesses one of the body’s immune cells, natural killer cells.

July 25, 2025

Vol.51 No.29

Rare pancreatic cancer shows strong response to immunotherapy

YOU MAY BE INTERESTED IN

Cancer Research Institute announces 2025 recipients of cancer immunotherapy awards

Blocking macropinocytosis changes TME, allows for more effective treatment, preclinical study shows

Six researchers awarded $5.3M for pancreatic cancer research by Stephenson Global

Dispatch Bio aims to deliver universal treatment across solid tumors with novel immunotherapy approach

SITC Forward Fund announces 2025 fellowship recipients

Study reveals immune-based therapy that may be effective in hard-to-treat lung cancers

Renew today!

Subscriber content

Never miss an issue!

Login